Skip to Main Content

Paper Details

Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer.
Nat Commun
52
2019
Author NameAffiliation
Ming ZhanRenji Hospital, Shanghai Jiao Tong University
  • 1 - 1

Datasets

Release 1.2